J Creaney

Summary

Affiliation: University of Western Australia
Country: Australia

Publications

  1. pmc Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma
    Jenette Creaney
    National Centre for Asbestos Related Diseases, University of Western Australia, School of Medicine and Pharmacology, Nedlands, Western Australia, Australia
    PLoS ONE 6:e26515. 2011
  2. pmc Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
    J Creaney
    National Research Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, University of Western Australia, Perth, Western Australia, Australia
    Br J Cancer 98:1562-9. 2008
  3. doi request reprint Serum and pleural fluid biomarkers for mesothelioma
    Jenette Creaney
    National Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, University of Western Australia, 4th Floor, G Block, Sir Charles Gairdner Hospital, Verdun St, Nedlands, WA 6009, Australia
    Curr Opin Pulm Med 15:366-70. 2009
  4. ncbi request reprint Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma
    Jenette Creaney
    National Research Centre for Asbestos Related Diseases, 4th Floor, G Block, Sir Charles Gairdner Hospital, Verdun St, Nedlands, WA 6009, Australia
    Chest 132:1239-46. 2007
  5. pmc Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma
    Jenette Creaney
    Department of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Verdun Ave, Nedlands 6009, Western Australia, Australia
    Thorax 62:569-76. 2007
  6. doi request reprint Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma
    Jenette Creaney
    National Research Centre for Asbestos Related Disease, Sir Charles Gairdner Hospital, 2School of Medicine and Pharmacology, University of Western Australia, QEII Medical Centre, Nedlands, Western Australia, Australia
    Cancer Epidemiol Biomarkers Prev 19:2238-46. 2010
  7. ncbi request reprint Sensitivity of urinary mesothelin in patients with malignant mesothelioma
    Jenette Creaney
    National Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia
    J Thorac Oncol 5:1461-6. 2010
  8. ncbi request reprint Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein
    Jenette Creaney
    School of Medicine and Pharmacology, University of Western Australia, 4th Floor, G Block, Sir Charles Gairdner Hospital, Nedlands 6009, Western Australia, Australia
    Hematol Oncol Clin North Am 19:1025-40, v. 2005
  9. doi request reprint Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden
    Jenette Creaney
    National Research Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
    Clin Cancer Res 17:1181-9. 2011
  10. doi request reprint Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best?
    Jenette Creaney
    National Research Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, 4th Floor, G Block, Verdun St, Nedlands, WA 6009, Australia
    Lung Cancer 74:55-60. 2011

Detail Information

Publications19

  1. pmc Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma
    Jenette Creaney
    National Centre for Asbestos Related Diseases, University of Western Australia, School of Medicine and Pharmacology, Nedlands, Western Australia, Australia
    PLoS ONE 6:e26515. 2011
    ..Therefore antibodies to neither vimentin nor ß-F1-ATPase are useful for differential diagnosis of MM, however high antibody levels to ß-F1-ATPase may be associated with increased survival and this warrants further investigation...
  2. pmc Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
    J Creaney
    National Research Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, University of Western Australia, Perth, Western Australia, Australia
    Br J Cancer 98:1562-9. 2008
    ....
  3. doi request reprint Serum and pleural fluid biomarkers for mesothelioma
    Jenette Creaney
    National Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, University of Western Australia, 4th Floor, G Block, Sir Charles Gairdner Hospital, Verdun St, Nedlands, WA 6009, Australia
    Curr Opin Pulm Med 15:366-70. 2009
    ..With the incidence of malignant mesothelioma expected to increase, it is timely to review the current status of biomarkers in this field...
  4. ncbi request reprint Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma
    Jenette Creaney
    National Research Centre for Asbestos Related Diseases, 4th Floor, G Block, Sir Charles Gairdner Hospital, Verdun St, Nedlands, WA 6009, Australia
    Chest 132:1239-46. 2007
    ..The purpose of this study was to study the mesothelin biomarker in a large patient cohort and to determine if another biomarker, CA125, improves on the sensitivity of mesothelin in the diagnosis of mesothelioma...
  5. pmc Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma
    Jenette Creaney
    Department of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Verdun Ave, Nedlands 6009, Western Australia, Australia
    Thorax 62:569-76. 2007
    ....
  6. doi request reprint Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma
    Jenette Creaney
    National Research Centre for Asbestos Related Disease, Sir Charles Gairdner Hospital, 2School of Medicine and Pharmacology, University of Western Australia, QEII Medical Centre, Nedlands, Western Australia, Australia
    Cancer Epidemiol Biomarkers Prev 19:2238-46. 2010
    ..In this study, soluble mesothelin was determined in sequential serum samples collected from asbestos-exposed individuals before the development of mesothelioma...
  7. ncbi request reprint Sensitivity of urinary mesothelin in patients with malignant mesothelioma
    Jenette Creaney
    National Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia
    J Thorac Oncol 5:1461-6. 2010
    ....
  8. ncbi request reprint Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein
    Jenette Creaney
    School of Medicine and Pharmacology, University of Western Australia, 4th Floor, G Block, Sir Charles Gairdner Hospital, Nedlands 6009, Western Australia, Australia
    Hematol Oncol Clin North Am 19:1025-40, v. 2005
    ....
  9. doi request reprint Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden
    Jenette Creaney
    National Research Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
    Clin Cancer Res 17:1181-9. 2011
    ..To examine the clinical utility of soluble mesothelin in patients with malignant pleural mesothelioma...
  10. doi request reprint Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best?
    Jenette Creaney
    National Research Centre for Asbestos Related Diseases, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, 4th Floor, G Block, Verdun St, Nedlands, WA 6009, Australia
    Lung Cancer 74:55-60. 2011
    ..As there is some concern about the sensitivity of osteopontin in serum versus plasma, we compared them in the same patient population to mesothelin...
  11. doi request reprint Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma
    Jenette Creaney
    National Research Centre for Asbestos Related Diseases, Western Australian Institute of Medical Research, School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Nedlands, Australia
    J Thorac Oncol 3:851-7. 2008
    ....
  12. ncbi request reprint Soluble mesothelin related protein in mesothelioma
    Jenette Creaney
    School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Wedlands, WA, Australia
    J Thorac Oncol 1:172-4. 2006
  13. pmc p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression
    J Creaney
    Western Australian Institute for Medical Research and University Department of Medicine, University of Western Australia, Queen Elizabeth II Medical Centre, 4th Floor, G Block, Nedlands, Perth, 6009, Western Australia
    Br J Cancer 84:52-6. 2001
    ..The occurrence of anti-p53 antibodies does not serve as either a useful prognostic or diagnostic indicator in MM...
  14. ncbi request reprint Soluble mesothelin-related protein--a blood test for mesothelioma
    Bruce W S Robinson
    University Department of Medicine, University of Western Australia, Queen Elizabeth II Medical Centre, Perth, WA, Australia
    Lung Cancer 49:S109-11. 2005
    ..SMRP should also be useful for monitoring disease progression, and importantly, may prove useful for screening asbestos-exposed individuals for early MM...
  15. ncbi request reprint Mesothelin-family proteins and diagnosis of mesothelioma
    Bruce W S Robinson
    University Department of Medicine, University of Western Australia, Queen Elizabeth II Medical Centre, Western Australia, Perth, Australia
    Lancet 362:1612-6. 2003
    ..Identification of such a marker would be useful in diagnosis of mesothelioma and for monitoring responses to treatment and screening at-risk individuals...
  16. ncbi request reprint Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma
    Alex Powell
    School of Medicine and Pharmacology, Sir Charles Gairdner Hospital Perth, Western Australia
    Lung Cancer 52:189-97. 2006
    ..We therefore evaluated the effect of an autologous MM tumor cell lysate, given s.c. with recombinant granulocyte-macrophage colony stimulating factor (GM-CSF), on anti-tumor immunity in patients with MM...
  17. doi request reprint Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study
    Eun Kee Park
    Research and Education Unit, Dust Disease Board, Level 2, 82 Elizabeth Street, Sydney, NSW 2000, Australia
    Am J Respir Crit Care Med 178:832-7. 2008
    ..Soluble mesothelin-related protein (SMRP) is raised in epithelial-type malignant mesothelioma (MM), but the utility of SMRP in screening for MM is unknown...
  18. ncbi request reprint A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions
    Andrew J Holloway
    Ian Potter Centre for Cancer Genomics and Predictive Medicine, Peter MacCallum Cancer Centre, East Melbourne, Australia
    Clin Cancer Res 12:5129-35. 2006
    ..We have therefore designed a gene expression-based test to classify the primary tumor causing a malignant pleural effusion, using cells collected from the effusion itself...
  19. doi request reprint Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study
    Oluf Dimitri Roe
    Department of Oncology, St Olavs Hospital, Trondheim University Hospital, Norway
    Lung Cancer 61:235-43. 2008
    ..Mesothelioma of the epithelial type of the peritoneum had a significantly longer survival than epithelial type in pleura and was also related to mesothelin expression...